Strong Trigger
now
Obtains final FDA approval for immunoncology drug 'Loqtorzi' for nasopharyngeal carcinoma; triggers institutional buying on incoming US commercial revenue.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |